Evidence map›Paper›PMID 21183644›Full record

ArticleApplied and environmental microbiology2011

Development and application of a method for counterselectable in-frame deletion in Clostridium perfringens.

Hirofumi Nariya, Shigeru Miyata, Motoo Suzuki, Eiji Tamai, Akinobu Okabe

Open access · greenAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Development of a conditional plasmid for gene deletion in non-modelApplied and environmental microbiology · 2025
    Article
  3. Article
  4. Article
  5. Potent Bile Acid Microbial Metabolites ModulatePathogens (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. A Putative Amidase Endolysin Encoded byAntibiotics (Basel, Switzerland) · 2021
    Article
  10. Article
  11. Article
  12. Science signaling · 2020
    Article
  13. An atypical lipoteichoic acid fromThe Journal of biological chemistry · 2020
    Article
  14. Article
  15. CRISPR Genome Editing Systems in the GenusJournal of bacteriology · 2019
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hirofumi NariyaDepartment of Microbiology, Faculty of Medicine, Kagawa University, 1750-1 Miki-cho, Kita-gun, Kagawa 761-0793, Japan. microbio@med.kagawa-u.ac.jp
Shigeru Miyata
Motoo Suzuki
Eiji Tamai
Akinobu Okabe
Matsuyama University · JPKagawa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many pathogenic clostridial species produce toxins and enzymes. To facilitate genome-wide identification of virulence factors and biotechnological application of their useful products, we have developed a markerless in-frame deletion method for Clostridium perfringens which allows efficient counterselection and multiple-gene disruption. The system comprises a galKT gene disruptant and a suicide galK plasmid into which two fragments of a target gene for in-frame deletion are cloned. The system was shown to be accurate and simple by using it to disrupt the alpha-toxin gene of the organism. It was also used to construct of two different virulence-attenuated strains, ΗΝ1303 and HN1314: the former is a disruptant of the virRS operon, which regulates the expression of virulence factors, and the latter is a disruptant of the six genes encoding the α, θ, and κ toxins; a clostripain-like protease; a 190-kDa secretory protein; and a putative cell wall lytic endopeptidase. Comparison of the two disruptants in terms of growth ability and the background levels of secreted proteins showed that HN1314 is more useful than ΗΝ1303 as a host for the large-scale production of recombinant proteins.

Indexed as

Sequence DeletionBacterial ProteinsBacterial ToxinsBase SequenceBlotting, NorthernCalcium-Binding ProteinsClostridium perfringensElectrophoresis, Polyacrylamide GelHemolysin ProteinsMicrobial CollagenaseMutagenesisPlasmidsReading FramesRecombinant ProteinsSequence Analysis, ProteinType C Phospholipasesalpha toxin, Clostridium perfringensBacterial ProteinsBacterial ToxinsCalcium-Binding ProteinsClostridium perfringens theta-toxinHemolysin Proteinskappa-toxin, Clostridium perfringensMicrobial CollagenaseRecombinant ProteinsType C PhospholipasesVirulence Factors

Identifiers

PMID21183644
PMCPMC3067250
OpenAlexW2151391555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.